AAAAAA

   
Results: 1-10 |
Results: 10
GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR - A NOVEL THERAPEUTIC APPROACH TO TREAT MOTOR DYSFUNCTION IN PARKINSONS-DISEASE
Authors: LAPCHAK PA GASH DM JIAO SS MILLER PJ HILT D
Citation: Pa. Lapchak et al., GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR - A NOVEL THERAPEUTIC APPROACH TO TREAT MOTOR DYSFUNCTION IN PARKINSONS-DISEASE, Experimental neurology, 144(1), 1997, pp. 29-34
ADENOVIRAL VECTOR-MEDIATED GDNF GENE-THERAPY IN A RODENT LESION MODELOF LATE-STAGE PARKINSONS-DISEASE
Authors: LAPCHAK PA ARAUJO DM HILT DC SHENG J JIAO SS
Citation: Pa. Lapchak et al., ADENOVIRAL VECTOR-MEDIATED GDNF GENE-THERAPY IN A RODENT LESION MODELOF LATE-STAGE PARKINSONS-DISEASE, Brain research, 777(1-2), 1997, pp. 153-160
GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR - DISTRIBUTION AND PHARMACOLOGY IN THE RAT FOLLOWING A BOLUS INTRAVENTRICULAR-INJECTION
Authors: LAPCHAK PA JIAO SS COLLINS F MILLER PJ
Citation: Pa. Lapchak et al., GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR - DISTRIBUTION AND PHARMACOLOGY IN THE RAT FOLLOWING A BOLUS INTRAVENTRICULAR-INJECTION, Brain research, 747(1), 1997, pp. 92-102
BIOLOGY OF GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR (GDNF) - IMPLICATIONS FOR THE USE OF GDNF TO TREAT PARKINSONS-DISEASE
Authors: LAPCHAK PA MILLER PJ JIAO SS ARAUJO DM HILT D COLLINS F
Citation: Pa. Lapchak et al., BIOLOGY OF GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR (GDNF) - IMPLICATIONS FOR THE USE OF GDNF TO TREAT PARKINSONS-DISEASE, Neurodegeneration, 5(3), 1996, pp. 197-205
ENHANCED DELIVERY OF [I-125] GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR TO THE RAT CNS FOLLOWING OSMOTIC BLOOD-BRAIN-BARRIER MODIFICATION
Authors: JIAO SS MILLER PJ LAPCHAK PA
Citation: Ss. Jiao et al., ENHANCED DELIVERY OF [I-125] GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR TO THE RAT CNS FOLLOWING OSMOTIC BLOOD-BRAIN-BARRIER MODIFICATION, Neuroscience letters, 220(3), 1996, pp. 187-190
PHARMACOLOGICAL CHARACTERIZATION OF GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR (GDNF) - IMPLICATIONS FOR GDNF AS A THERAPEUTIC MOLECULE FOR TREATING NEURODEGENERATIVE DISEASES
Authors: LAPCHAK PA JIAO SS MILLER PJ WILLIAMS LR CUMMINS V INOUYE G MATHESON CR YAN Q
Citation: Pa. Lapchak et al., PHARMACOLOGICAL CHARACTERIZATION OF GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR (GDNF) - IMPLICATIONS FOR GDNF AS A THERAPEUTIC MOLECULE FOR TREATING NEURODEGENERATIVE DISEASES, Cell and tissue research, 286(2), 1996, pp. 179-189
LONG-TERM CORRECTION OF RAT MODEL OF PARKINSONS-DISEASE BY GENE-THERAPY (VOL 362, PG 450, 1993)
Authors: JIAO SS GUREVICH V WOLFF JA
Citation: Ss. Jiao et al., LONG-TERM CORRECTION OF RAT MODEL OF PARKINSONS-DISEASE BY GENE-THERAPY (VOL 362, PG 450, 1993), Nature, 380(6576), 1996, pp. 734-734
PHARMACOLOGICAL ENHANCEMENT OF IN-VIVO FOREIGN GENE-EXPRESSION IN MUSCLE
Authors: DANKO I FRITZ JD JIAO SS HOGAN K LATENDRESSE JS WOLFF JA
Citation: I. Danko et al., PHARMACOLOGICAL ENHANCEMENT OF IN-VIVO FOREIGN GENE-EXPRESSION IN MUSCLE, Gene therapy, 1(2), 1994, pp. 114-121
INDUCTION OF SPECIFIC TOLERANCE BY INTRATHYMIC INJECTION OF RECIPIENTMUSCLE-CELLS TRANSFECTED WITH DONOR CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX
Authors: KNECHTLE SJ WANG J JIAO SS GEISSLER EK SUMIMOTO R WOLFF J
Citation: Sj. Knechtle et al., INDUCTION OF SPECIFIC TOLERANCE BY INTRATHYMIC INJECTION OF RECIPIENTMUSCLE-CELLS TRANSFECTED WITH DONOR CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX, Transplantation, 57(7), 1994, pp. 990-996
CO-TRANSPLANTATION OF PLASMID-TRANSFECTED MYOBLASTS AND MYOTUBES INTORAT BRAINS ENABLES HIGH-LEVELS OF GENE-EXPRESSION LONG-TERM
Authors: JIAO SS WILLIAMS P SAFDA N SCHULTZ E WOLFF JA
Citation: Ss. Jiao et al., CO-TRANSPLANTATION OF PLASMID-TRANSFECTED MYOBLASTS AND MYOTUBES INTORAT BRAINS ENABLES HIGH-LEVELS OF GENE-EXPRESSION LONG-TERM, Cell transplantation, 2(3), 1993, pp. 185-192
Risultati: 1-10 |